Latest Italy News

Page 8 of 13
Altamin Limited has locked in $753,000 through a share placement to cover part of its entitlement offer shortfall, attracting sophisticated investors from the UK and Australia.
Maxwell Dee
Maxwell Dee
9 Dec 2025
Keybridge Capital Limited is navigating a complex recovery with new board leadership, partial loan repayments, and favorable court rulings against former executives. The company is steadily addressing legacy financial and legal challenges.
Claire Turing
Claire Turing
26 Nov 2025
Altamin Limited has appointed GBA Capital as lead manager to place shortfall shares from its recent entitlement offer, offering broker options as part of the arrangement. This move aims to bolster support for its critical minerals projects in Italy while engaging new and existing investors.
Maxwell Dee
Maxwell Dee
19 Nov 2025
ADX Energy has raised A$3.5 million through a placement to fund key gas exploration projects in Austria and Italy, alongside plans for a strategic dual listing in Oslo.
Maxwell Dee
Maxwell Dee
13 Nov 2025
AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.
Ada Torres
Ada Torres
7 Nov 2025
Altamin Limited has advanced its geothermal lithium ambitions with a significant A$3.62 million grant from the Italian government, alongside strategic board changes and a $4.39 million capital raise.
Maxwell Dee
Maxwell Dee
31 Oct 2025
ADX Energy reports a 17% production dip in Q3 2025 due to well downtime but boosts sales revenue by 23%, while advancing drilling plans and acquiring key infrastructure.
Maxwell Dee
Maxwell Dee
31 Oct 2025
Po Valley Energy reported consistent gas production and strong cash flow in Q3 2025, while advancing development plans and a new gas sales agreement in Italy.
Maxwell Dee
Maxwell Dee
31 Oct 2025
OncoSil Medical reports a remarkable 917% increase in quarterly cash receipts alongside promising clinical trial results and key European market entries, signaling robust momentum in its pancreatic cancer treatment rollout.
Ada Torres
Ada Torres
30 Oct 2025
Fluence Corporation reported a robust 72.9% revenue increase in Q3 2025, driven by a strategic pivot towards higher-margin Smart Product Solutions and recurring revenue streams. The company maintains its full-year guidance despite expecting to finish near the lower end.
Victor Sage
Victor Sage
30 Oct 2025
Fluence Corporation reported a robust 72.9% revenue increase year-to-date Q3 2025, fueled by the Ivory Coast Addendum project, while maintaining its full-year guidance despite some margin pressures.
Victor Sage
Victor Sage
30 Oct 2025
Fluence Corporation Limited reported a solid cash flow position for Q3 2025, with positive net cash from operations and strong liquidity supported by available financing facilities.
Sophie Babbage
Sophie Babbage
30 Oct 2025

Browse the archive

Full archive